Opportunities for Public Comment on Nominees for CIRM Chair
Directors of the California stem cell agency are planning at least three public meetings prior to making their decision on cardiologist Frank Litvack or bond financier Jonathan Thomas to replace outgoing chairman Robert Klein at the end of June.
The public will have a chance to weigh in with comments at all of the meetings. Two sessions have telephonic …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.